medigraphic.com
SPANISH

Revista de Enfermedades no Transmisibles Finlay

ISSN 2221-2434 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 1

<< Back Next >>

Finlay 2015; 5 (1)

Inflammatory acute response. Biochemical and cellular considerations

León RML, Alvarado BA, de Armas GJO, Miranda AL, Varens CJA, Cuesta SJÁ
Full text How to cite this article

Language: Spanish
References: 20
Page: 47-62
PDF size: 185.57 Kb.


Key words:

systemic inflammatory response syndrome, biochemical processes, cells.

ABSTRACT

The acute inflammation constitutes a natural, protective-character response that intends to free the organism of the initial cause of the cell lesion and of the consequences that it provokes. The present work aimed at argumenting on the mechanisms that explain the vascular changes, and the establishment of the signs of the acute inflammatory response with an in-depth molecular level. 18 articles of scientific magazines, 2 books and other sources of information that was accessed by means of the principal managers of the computer network, adding up a total of 20 sources, were consulted. Right after a cell lesion; a complex group of biochemical and cell interactions begins, mediated for the activity of multiple chemical agents, which provoke changes in the microvasculature, as well as an increasement of leucocytes at the lesion's zone, and finally the acute inflammatory response's signs.


REFERENCES

  1. Kumar V, Abbas AK, Fausto N, Mitchell RN. Acute and chronic inflammation. In: Saunders (Elsevier). Robbins & Cotran Pathologic Basis of Disease. 8th. ed. New York: McGraw-Hill Interamericana; 2007. p. 58-31.

  2. Cook JM, Deem TL. Active participation of endothelial cells in inflammation. J Leukoc Biol. 2005 ; 77 (4): 487-95.

  3. Munford RS. Severe sepsis and septic shock: the role of gram-negative bacteremia. Annu Rev Pathol. 2006 ; 1 (1): 467-96.

  4. Guyton AC, Hall JE. Tratado de Fisiología Médica. 11va. ed. Philadelphia: Elsevier; 2006.

  5. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood. 2008 ; 15 (112): 935-45.

  6. Gómez RA, Guerra T, Dita L, Fernández JD, Cabrera M. Teoría celular de la coagulación: de las cascadas a las membranas celulares. Medisur [revista en Internet]. 2011 ; 9 (2): [aprox. 10p]. Available from: http://www.medisur.sld.cu/index.php/medisur/arti cle/view/1177/633.

  7. Ganter MT, Pittet JF. New insights into acute coagulopathy in trauma patients. Best Pract Res Clin Anaesthesiol. 2010 ; 24 (1): 15-25.

  8. Kluger MA, Zahner G, Paust HJ, Schaper M, Magnus T, Panzer U, et al. Leukocyte-derived MMP9 is crucial for the recruitment of proinflammatory macrophages in experimental glomerulonephritis. Kidney Int. 2013 ; 83 (5): 865-77.

  9. Roca J, Pujols L, Agusti C, Xaubet A, Mullol J, Gimferrer JM, et al. La ciclooxigenasa-2 está regulada al alza en el pulmón y en los tumores bronquiales de pacientes con enfermedad pulmonar obstructiva crónica. Arch Bronconeumol. 2011 ; 47 (12): 584-9.

  10. Cañete J. Bitopatología de la membrana sinovial en la artritis psoriasica. Reumatol Clin. 2012 ; 8 Suppl 1: SS10-S14.

  11. Bugatti S, Manzo A, Bombardieri M, Vitolo B, Humby F, Kelly S, et al. Synovial tissue heterogeneity and peripheral blood biomarkers. Curr Rheumatol Rep. 2011 ; 13 (5): 440-8.

  12. Fernández MA, Gebara E. Hiperostosis cortical neonatal. Un efecto colateral de la administración prolongada de prostaglandinas E1. Arch argent pediatr. 2011 ; 109 (2): 154-9.

  13. Kalloghlian AK, Frayha HH, de Moor MM. Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion. Eur J Pediatr. 1996 ; 155 (3): 173-4.

  14. Li L, Fox B, Keeble J, Salto M, Winyard P, Wood M, et al. The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. J Cell Mol Med. 2013 ; 17 (3): 365-76.

  15. Bouchaud G, Gehrke S, Krieg C, Kolios A, Hafner J, Navarini A, et al. Epidermal IL-15Ra acts as an endogenous antagonist of psoriasiform inflammation in mouse and man. J Exp Med. 2013 ; 210 (10): 2105-17.

  16. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002 ; 105 (9): 1135-43.

  17. Van P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol. 2007 ; 82 (6): 1375-81.

  18. Savill J. Apoptosis in resolution of inflammation. J Leukoc Biol. 1997 ; 61 (4): 375-80.

  19. Ildefonso JA, Arias J. Fisiopatología de la lesión hepática por isquemia-reperfusión. CIRESP. 2010 ; 87 (4): 202-9.

  20. Del Puerto L, Pérez S, Girón A, Peces G. Papel de la inflamación en la etiopatogenia de la EPOC. Arch Bronconeumol. 2010 ; 46 Suppl 11: S2-7.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Finlay. 2015;5